- Home
- DSGX vs ASND Comparison
DSGX vs ASND Comparison
Compare DSGX & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGX
- ASND
- Stock Information
- Founded
- DSGX 1981
- ASND 2006
- Country
- DSGX Canada
- ASND Denmark
- Employees
- DSGX N/A
- ASND N/A
- Industry
- DSGX Computer Software: Prepackaged Software
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- DSGX Technology
- ASND Health Care
- Exchange
- DSGX Nasdaq
- ASND Nasdaq
- Market Cap
- DSGX N/A
- ASND 7.7B
- IPO Year
- DSGX 1999
- ASND 2015
- Fundamental
- Price
- DSGX $106.53
- ASND $123.00
- Analyst Decision
- DSGX Buy
- ASND Strong Buy
- Analyst Count
- DSGX 11
- ASND 13
- Target Price
- DSGX $106.00
- ASND $195.92
- AVG Volume (30 Days)
- DSGX 116.3K
- ASND 391.4K
- Earning Date
- DSGX 12-03-2024
- ASND 11-05-2024
- Dividend Yield
- DSGX N/A
- ASND N/A
- EPS Growth
- DSGX 13.00
- ASND N/A
- EPS
- DSGX 1.48
- ASND N/A
- Revenue
- DSGX $607,697,000.00
- ASND $340,327,869.00
- Revenue This Year
- DSGX $13.91
- ASND $16.12
- Revenue Next Year
- DSGX $10.76
- ASND $87.44
- P/E Ratio
- DSGX $72.41
- ASND N/A
- Revenue Growth
- DSGX 15.40
- ASND 166.54
- 52 Week Low
- DSGX $70.92
- ASND $86.55
- 52 Week High
- DSGX $108.02
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- DSGX 57.33
- ASND 39.09
- Support Level
- DSGX $103.61
- ASND $124.02
- Resistance Level
- DSGX $107.38
- ASND $133.97
- Average True Range (ATR)
- DSGX 1.76
- ASND 3.67
- MACD
- DSGX -0.09
- ASND -0.33
- Stochastic Oscillator
- DSGX 65.53
- ASND 15.18
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.